Characterizations of Biocompatible and Bioactive Hydroxyapatite Particles  by Salimi, M.N. & Anuar, A.
 Procedia Engineering  53 ( 2013 )  192 – 196 
1877-7058 © 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.
Selection and peer-review under responsibility of the Research Management & Innovation Centre, Universiti Malaysia Perlis
doi: 10.1016/j.proeng.2013.02.025 
Malaysian Technical Universities Conference on Engineering & Technology 2012, MUCET 2012
Part 3 - Civil and Chemical Engineering 
Characterizations of Biocompatible And Bioactive Hydroxyapatite 
Particles
M. N. Salimiª*, A. Anuarª
a School of Bioprocess Engineering
Universiti Malaysia Perlis (UniMAP), Jejawi, Perlis.
Abstract
The most common gene vectors used are virus based (viral gene vectors). These possess high immunological risk, so a non-viral gene 
vector maybe preferable. Nanocrystalline hydroxyapatite, HAp [Ca10(PO4)6(OH)2] is an example of a possible non-viral gene vector. This
is due to its good biocompatibility, bioactivity and proven results as a non-viral gene vector. The HAp particles produced in this study was
by the sol-gel method and the processing conditions were varied in terms of the processing temperatures (20 oC, 30 oC or 40 oC) and the 
stirring rates (200 rpm, 400 rpm or 600 rpm). The particles formed from all of the processing conditions were systematically characterized
and compared to each other. The characterizations performed were FTIR, for identifying functional groups, XRD for phase composition, 
The characterizations data 
obtained showed that the functional groups, phase composition, crystallinity and surface morphology were similar for all of the samples,
the only difference being on the calculated particle size. It also showed that, at a lower processing temperature and higher stirring rate,
smaller particle sizes were formed.
© 2013 The Authors. Published by Elsevier Ltd.
Selection and/or peer-review under responsibility of the Research Management & Innovation Centre, Universiti Malaysia
Perlis.
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1. Introduction
Calcium phosphates are of interest for many biomedical applications due to their good boicompability and bioactivity
(Figure 1). Hydroxyapatite (HAp) has been used as implant coating [1] and substitutes [2]. Also, calcium phosphate
nanoparticles have a range of applications in a number of fields, such as drug delivery, gene therapy (Figure 2), bone 
cements, dental applications, chromatography and waste water remediation. Each application has a need for the
nanoparticles to be of a particular size range. There are various techniques reported in the literature for the production of 
nanosized calcium phosphate particles. These include wet chemical precipitation [3], sol-gel synthesis [4], hydrothermal
synthesis [5], mechano-chemical synthesis [6] and several other methods by which nanoparticle of various shapes and sizes
can be obtained.
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Fig. 1.  Schematic model of an affinity binding between a nHAp crystal and DNA [1]. 
 
 
 
Fig. 2. Mechanism of cellular uptake of non-viral gene vectors (via endocytosis). 
 Specific characteristics of particles (size, shape, surface, crystal structure and morphology) are among the important 
factors needed to control technological and biopharmaceutical properties of drug products. In general, morphology (crystal 
habit) can influence the physical and chemistry stability of solid dosage forms, a narrow size distribution is important to 
obtain content uniformity, while spherical particles allow good flowability and tablettability. Furthermore, micronisation 
increases the surface area with a consequent increase of dissolution rate and bioavailability of the drug, thus promoting the 
formulation of active principle ingredients which may be insoluble or slightly soluble in aqueous media. 
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2. Experimental Method 
A stoichiometric amount of aqueous solution of calcium nitrate tetrahydrate [Ca(NO3)2.4H2O] was used and mixed with 
aqueous solution of ammonium phosphate (NH4)3PO4 with the molar ratio of 10:6 by using a peristaltic pump into a stirred 
beaker. This Ca/P molar ratio is the desired Ca/P ratio as observed in HAp. In mixing step, the processing conditions were 
varied in terms of the processing temperatures    (20 oC, 30 oC or 40 oC) and the stirring rates (200 rpm, 400 rpm or 600 
rpm). The concentrations of both precursors, which were the calcium nitrate tetrahydrate and ammonium phosphate and also 
samples were then dried at a temperature of 100 oC and the drying step was carried out for 24 hour. Lastly, the dried 
samples were crushed using a pastle and mortar apparatus for 5 minutes. The procedure for the production of nanoparticles 
is outlined in Figure 3. 
The particles formed from all of the processing conditions were systematically characterized and compared to each other. 
The characterizations performed were FTIR, for identifying functional groups, XRD for phase composition, crystallinity 
ula) and SEM for surface morphology. 
 
 
 
Fig. 3.  Flow chart of the sol-gel synthesis of hydroxyapatite powder 
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3. Results and Discussion 
Phosphate and hydroxide absorption peaks for HAp were seen in the FTIR spectra (Figure 4). The formation of 
HAp was indicated by the characteristic peak occurring at 2  = 31.8o, which appeared on all of the HAp samples (Figure 5). 
 
 
Fig. 4. The FTIR spectra for hydroxyapatite samples prepared at 200, 400, 600 rpm and 30 oC 
 
 
 
 
Fig. 5.  The XRD patterns for hydroxyapatite samples prepared at 200, 400, 600 rpm and 30 oC 
 
of HAp nanoparticles showed that the particles formed agglomerates of approximately <  
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(a) 200 rpm &      20 oC (b) 600 rpm &      30 oC 
(c) 200 rpm &              20 oC  (d) 600 rpm &               30 oC 
 
Fig. 6.  The SEM images for hydroxyapatite samples prepared at 200 & 600 rpm and 20 & 30 oC 
4. Conclusion 
The characterizations data obtained showed that the functional groups, phase composition, crystallinity and surface 
morphology were similar for all of the samples, the only difference being on the calculated particle size. It also showed that, 
at a lower processing temperature and higher stirring rate, smaller particle sizes were formed.  
References 
[1] L. Sun, C. C. Berndt, A. Kucuk and K. A. Gross. Material fundamentals and clinical performance of plasma sprayed hydroxyapatite coatings. Review, 
Appl. Biomat., 58 (5) (2001) p. 570  592. 
[2] H. R. R. Ramay and M. Zhang. Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering.  Biomaterials., 
25 (2004), p. 5171  5180. 
[3] N. Degirmenbasi, D. M. Kaylon and E. Birinci. Biocomposites of nanohydroxyapatite with collagen and poly(vinyl alcohol). Colloids. Surf B., 48 
(2006), p. 42  49. 
[4] S. J. Kalita and H. A. Bhatt. Nanocrystalline hydroxyapatite doped with magnesium and zinc: synthesis and characterization. Mater. Sci. Eng., 27 
(2007), p. 837  848. 
[5] S. Pushpakanth, B. Srinivasan, B. Sreedhar and T. P. Sastry. An in-situ approach to prepare nanorods of titania-hydroxyapatite (TiO2-HAp) 
nanocomposite by microwave hydrothermal technique. Mater. Chem. Phys., 107 (2008), p. 492  498. 
[6] L. Wang, R. Nemoto and M. Senna. Microstructure and chemical states of hydroxyapatite/silk fibroin nanocomposites synthesized via a wet 
mechanochemical route. J. Nanopart. Res., 4 (2002), p. 535  540. 
 
 
